Abstract:Malaria infections are common occurrences and one of the leading causes of death in developing countries. The World Health Organization reported 212 million malaria cases worldwide in 2016 which resulted in 429,000 deaths. The most affected group of individuals were children under the age of five which accounted for 70% of this death rate. There are no available vaccines for malaria, but the development of this type of treatment would provide a more cost‐effective and efficient way of battling this disease. Within populations affected by malaria, certain children and adolescents have developed protective immune responses against this disease. These protective immune responses decrease the intensity of the infection thus making the individual more resistant against the acquired disease. Through differential screening experiments, malarial‐protein antigens recognized by antibodies from resistant, but not susceptible individuals were discovered. The Plasmodium falciparum Glutamic Acid‐Rich Protein (PfGARP), an antigen that arrests the development of the parasite in its trophozoite stage was discovered using this method. The specific aim of this study was to express functional PfGARP in order to purify and characterize it as a vaccine candidate. The PfGARP gene was inserted into a plasmid vector that was then used to transform the expression system organism: Pichia pastoris. Individual colonies of recombinant P. pastoris were transferred from agar plates to liquid medium cultures. These were then analyzed for protein expression via Western blot every 24 hours after induction of protein expression. 94 colonies of recombinant P. pastoris were analyzed using this method and none showed expression of PfGARP. PCR analyses were then performed to determine the presence of the PfGARP gene in transformed P. pastoris. A set of vector‐specific primers was designed to amplify a region of 2242 base pairs which included the PfGARP gene in the middle of the region. Amplifications from DNA extracted from the recombinant cells showed a band size of roughly 1000 base pairs. Based on results from the Western blot and PCR analyses performed, it can be concluded that P. pastoris deletes a significant amount of the PfGARP gene's sequence and therefore is not a viable protein expression system for PfGARP. Support or Funding Information Research reported in this publication was supported by the National Institute Of General Medical Sciences of the National Institutes of Health under Award Number T34GM008419. This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Constructing a Pre-Erythrocytic Multi-Epitope Chimeric Antigen of Plasmodium Falciparum and Its Expression in Pichia Pastoris

Expression,purification and initial identification of the multi-epitope gene of Plasmodium vivax in Pichia pastoris

Expression of Plasmodium falciparum Glutamic Acid‐Rich Protein (PfGARP) in Recombinant Pichia pastoris for Malaria Vaccine Development

Construction,expression and Characterization of Recombinant Fusion Protein HSA-PTH(1-34) in Pichia Pastoris

Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.

[Preparation and Characterization of Monoclonal Antibody Specific to PfCP-2.9 Chimeric Protein of Plasmodium Falciparum].

Blood-Stage Vaccine Candidate of Plasmodium Falciparum

Identification of cultivation condition to produce correctly folded form of a malaria vaccine based on Plasmodium falciparum merozoite surface protein-1 in Escherichia coli

Recombinant expression of multiepitope fusion polypeptide derived from Mycobacterium tuberculosis(Mtb.) antigens

Construction Recombinant Plasmid of the Chlamydia Pneumoniae Outer Membrane Protein Gene

Solution structure of a Plasmodium falciparum AMA-1/MSP 1 chimeric protein vaccine candidate (PfCP-2.9) for malaria

[Expression of Chimeric Protein of Plasmodium Falciparum in Yeast Recombinant Pichia Pastoris in Cell-High-density Fermentation].

Engineering the chloroplast of Chlamydomonas reinhardtii to express the recombinant PfCelTOS-Il2 antigen-adjuvant fusion protein

Rice‐produced MSP142 of Plasmodium Falciparum Elicits Antibodies That Inhibit Parasite Growth in Vitro

High-level expression of codon optimized foot-and-mouth disease virus complex epitopes and cholera toxin B subunit chimera in Hansenula polymorpha.

Semiautomated design and soluble expression of a chimeric antigen TbpAB01 from Glaesserella parasuis

Effects of vector fusion peptides on the conformation and immune reactivity of epitope-shuffled, recombinant multi-epitope antigens.

Expression of the Recombinant Fusion Protein Cp15-23 of Cryptosporidium Parvum and Its Protective Test

[Construction of Fusion Gene Vaccine of WT1 Multi-Epitope Fused with Stimulating Epitope of Mycobacterium Tuberculosis Heat Shock Protein 70 and Its Expression and Immunogenicity].

Secretory Expression of Chimeric Fab Antibody HAb18 Against Human Hepatocellular Carcinoma in Pichia Pastoris

Vaccine co-display of CSP and Pfs230 on liposomes targeting two Plasmodium falciparum differentiation stages